Your browser doesn't support javascript.
loading
An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation.
Svinarenko, Michael; Katz, Sarah-Fee; Tharehalli, Umesh; Mulaw, Medhanie A; Maier, Harald J; Sunami, Yoshiaki; Fischer, Sarah K; Chen, Yuexin; Heurich, Sabine; Erkert, Lena; Tannapfel, Andrea; Wirth, Thomas; Schirmbeck, Reinhold; Seufferlein, Thomas; Lechel, André.
Affiliation
  • Svinarenko M; Department of Internal Medicine I, University Hospital Ulm, 89081 Ulm, Germany. michael.svinarenko@uni-ulm.de.
  • Katz SF; Department of Internal Medicine I, University Hospital Ulm, 89081 Ulm, Germany. sarah-fee.katz@web.de.
  • Tharehalli U; Department of Internal Medicine I, University Hospital Ulm, 89081 Ulm, Germany. umesh.tharehalli@uni-ulm.de.
  • Mulaw MA; Institute of Experimental Cancer Research, Comprehensive Cancer Center Ulm, University Hospital Ulm, 89081 Ulm, Germany. medhanie.mulaw@uni-ulm.de.
  • Maier HJ; Department of Internal Medicine I, University Hospital Ulm, 89081 Ulm, Germany. maierhj@gmail.com.
  • Sunami Y; Institute of Physiological Chemistry, Ulm University, 89081 Ulm, Germany. maierhj@gmail.com.
  • Fischer SK; Department of Visceral, Vascular and Endocrine Surgery, Halle University Hospital, Martin-Luther University Halle-Wittenberg, 06120 Halle, Germany. yoshiaki.sunami@uk-halle.de.
  • Chen Y; Department of Internal Medicine I, University Hospital Ulm, 89081 Ulm, Germany. sarah.k.f.91@googlemail.com.
  • Heurich S; Department of Internal Medicine I, University Hospital Ulm, 89081 Ulm, Germany. yuexin.chen@tum.de.
  • Erkert L; Center for Translational Cancer Research (TranslaTUM), Technical University Munich, 81675 Munich, Germany. yuexin.chen@tum.de.
  • Tannapfel A; Department of Internal Medicine II, Klinikum rechts der Isar, Technical University Munich, 81675 Munich, Germany. yuexin.chen@tum.de.
  • Wirth T; Department of Internal Medicine I, University Hospital Ulm, 89081 Ulm, Germany. sabine.heurich@uni-ulm.de.
  • Schirmbeck R; Department of Internal Medicine I, University Hospital Ulm, 89081 Ulm, Germany. lena.erkert@t-online.de.
  • Seufferlein T; Institute of Pathology, Ruhr University Bochum, 44789 Bochum, Germany. andrea.tannapfel@pathologie-bochum.de.
  • Lechel A; Institute of Physiological Chemistry, Ulm University, 89081 Ulm, Germany. thomas.wirth@uni-ulm.de.
Cancers (Basel) ; 11(10)2019 Sep 21.
Article in En | MEDLINE | ID: mdl-31546614
ABSTRACT

BACKGROUND:

Most liver tumors arise on the basis of chronic liver diseases that trigger inflammatory responses. Besides inflammation, subsequent defects in the p53-signaling pathway frequently occurs in liver cancer. In this study, we analyzed the consequences of inflammation and p53 loss in liver carcinogenesis.

METHODS:

We used inducible liver-specific transgenic mouse strains to analyze the consequences of NF-κB/p65 activation mimicking chronic inflammation and subsequent p53 loss.

RESULTS:

Ikk2ca driven NF-κB/p65 activation in mice results in liver fibrosis, the formation of ectopic lymphoid structures and carcinogenesis independent of p53 expression. Subsequent deletion of Trp53 led to an increased tumor formation, metastasis and a shift in tumor differentiation towards intrahepatic cholangiocarcinoma. In addition, loss of Trp53 in an inflammatory liver resulted in elevated chromosomal instability and indicated a distinct aberration pattern.

CONCLUSIONS:

In conclusion, activation of NF-κB/p65 mimicking chronic inflammation provokes the formation of liver carcinoma. Collateral disruption of Trp53 supports tumor progression and influences tumor differentiation and heterogeneity.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2019 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2019 Type: Article Affiliation country: Germany